DK0521524T3 - Aminooxypyrrolidinylthiocarbapenem-forbindelser - Google Patents

Aminooxypyrrolidinylthiocarbapenem-forbindelser

Info

Publication number
DK0521524T3
DK0521524T3 DK92111356.9T DK92111356T DK0521524T3 DK 0521524 T3 DK0521524 T3 DK 0521524T3 DK 92111356 T DK92111356 T DK 92111356T DK 0521524 T3 DK0521524 T3 DK 0521524T3
Authority
DK
Denmark
Prior art keywords
hydrogen
protective group
aminooxypyrrolidinylthiocarbapenem
thiol
imino
Prior art date
Application number
DK92111356.9T
Other languages
Danish (da)
English (en)
Inventor
Yuji Sendo
Makoto Kii
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0521524T3 publication Critical patent/DK0521524T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
DK92111356.9T 1991-07-04 1992-07-03 Aminooxypyrrolidinylthiocarbapenem-forbindelser DK0521524T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16424791 1991-07-04

Publications (1)

Publication Number Publication Date
DK0521524T3 true DK0521524T3 (da) 1997-05-05

Family

ID=15789474

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92111356.9T DK0521524T3 (da) 1991-07-04 1992-07-03 Aminooxypyrrolidinylthiocarbapenem-forbindelser

Country Status (10)

Country Link
US (2) US5360798A (ja)
EP (1) EP0521524B1 (ja)
JP (1) JP3296845B2 (ja)
KR (1) KR100215514B1 (ja)
AT (1) ATE151424T1 (ja)
DE (1) DE69218843T2 (ja)
DK (1) DK0521524T3 (ja)
ES (1) ES2103014T3 (ja)
GR (1) GR3023607T3 (ja)
TW (1) TW208008B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
AU4020897A (en) 1996-08-17 1998-03-06 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
CN1107067C (zh) * 1997-02-07 2003-04-30 京都药品工业株式会社 碳代青霉烯化合物、其用途及其中间体化合物
CA2330641A1 (en) 1998-05-01 1999-11-11 Kyoto Pharmaceutical Industries, Ltd. Carbapenem derivatives, utilization thereof and intermediate compounds of the same
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
BR0112656A (pt) 2000-07-19 2003-06-24 Hoffmann La Roche Compostos, composições farmacêuticas que contêm os mesmos, utilização desses compostos,: processo para tratamento terapêutico e/ou profilático e processo para a preparação desses compostos
PL366943A1 (en) * 2001-05-21 2005-02-07 Kyoto Pharmaceutical Industries, Ltd. Carbapenem compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251541A (en) * 1979-01-09 1981-02-17 A. H. Robins Company, Inc. 1-Substituted-3-arylthio-4-hydroxypyrrolidines
EP0182213B1 (en) * 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
EP0243686B1 (en) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
GB8811237D0 (en) * 1988-05-12 1988-06-15 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives

Also Published As

Publication number Publication date
KR930002350A (ko) 1993-02-23
KR100215514B1 (ko) 1999-08-16
EP0521524B1 (en) 1997-04-09
DE69218843T2 (de) 1997-10-09
TW208008B (ja) 1993-06-21
US5523415A (en) 1996-06-04
JPH05186467A (ja) 1993-07-27
DE69218843D1 (de) 1997-05-15
ATE151424T1 (de) 1997-04-15
ES2103014T3 (es) 1997-08-16
EP0521524A1 (en) 1993-01-07
US5360798A (en) 1994-11-01
GR3023607T3 (en) 1997-08-29
JP3296845B2 (ja) 2002-07-02

Similar Documents

Publication Publication Date Title
AU2267195A (en) Dc-89 derivative
ES2144421T3 (es) Nuevo derivado tetrapeptidico.
DE69127457D1 (en) 6-0-methylerythromycin a-derivat
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
DK0736030T3 (da) Fungicide tetrahydrofuraner
EP0711768A4 (en) BENZIMIDAZOLE DERIVATIVES
ES2110749T3 (es) Derivado de azolilamina.
BR9407169A (pt) Derivados de pirazol
ES2117264T3 (es) Nuevo compuesto con actividad inhibitoria de la agregacion plaquetaria.
ES8606360A1 (es) Un derivado de cefalosporina.
DK0521524T3 (da) Aminooxypyrrolidinylthiocarbapenem-forbindelser
ES2109993T3 (es) Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables.
DE69423339D1 (de) Epoxycyclohexendionderivat
AU8226891A (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
AU4732096A (en) Remedy for pulmonary heart
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
EP0421668A3 (en) 1,4-dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents